Industry Relations Council

The HOPA Industry Relations Council (IRC) is comprised of pharmaceutical and medical device companies that are interested in supporting hematology/oncology pharmacists and making a connection to key leaders in the field.

We recently rolled out a tiered IRC program, which makes it easier for companies of all sizes to participate. IRC benefits have also been enhanced so there are ample opportunities for participating companies to engage with HOPA members in meaningful ways.

When you become an IRC partner, your organization will gain valuable insight into the challenges and needs of hematology/oncology pharmacists. You will see how our members balance good clinical assessments with smart economic decisions. And, together we will improve how cancer care is delivered and how patients with cancer are treated within this highly specialized field.

HOPA IRC Highlights

The HOPA IRC connects you to hematology/oncology pharmacists in meaningful ways. Your IRC participation:

Provides a format for establishing and building relationships
Fosters open dialogue among key industry representatives who have ties to the specialty of hematology/oncology pharmacy
Allows participants to gain a greater understanding of mutual areas of interest
Advances programs that promote optimal, cost-effective care for people affected by cancer

Thank you to our current IRC Partners!

The IRC was created to offer organizations the opportunity to collaborate with HOPA to achieve our mission to advance oncology pharmacy practice by supporting hematology/oncology pharmacy practitioners in optimizing cancer patient care. Thank you to our current IRC for their continued partnership and support.

View the full list of HOPA's IRC Partners

IRC Participant Benefits

IRC participants may receive the following benefits:

Complementary registration for HOPA's Annual Conference and invitation to an industry networking reception
Invitation for company representatives to attend HOPA's Industry Relations Council Annual Summit
- Last year almost 90 participants including IRC Partners, HOPA Board, Industry Advisory Group and HOPA Staff engaged in a lively discussion focused on Biomarker Testing, Real World Evidence and Shared Learning.
Opportunity to conduct an advisory board with HOPA member experts on select topics
- Virtual or in person at HOPA's Annual Conference
One-on-One meeting for company representatives to engage with HOPA’s Board to identify areas of strategic alignment
Listing of Patient Assistance Programs and Key Clinical Trials on HOPA’s website

Download the 2024 IRC Brochure for full list of benefits

Ready to Formalize your Relationship?

Participation in HOPA's Industry Relations Council is open to all organizations that support our mission and the work of hematology/oncology pharmacists. When you become an IRC participant, you are in very good company - the IRC consists of both new and established brands in pharmaceuticals, medical devices, and industry publications.

For more information contact Laurie Rappa, Senior Development Director, at 877.467.2791 or lrappa@hoparx.org.